Lantheus Holdings, Inc. (28)

Browse by Contract Category

Contracts

Indenture (including Form of Note) with respect to the Companys 2.625% Convertible Senior Notes due 2027, dated as of December 8, 2022, among Lantheus Holdings, Inc., Lantheus... (Filed With SEC on December 8, 2022)
License and Collaboration Agreement between Point Biopharma , Inc. and Lantheus Three, LLC, dated as of November 11, 2022 (Filed With SEC on November 14, 2022)
Sixth Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan (Filed With SEC on May 2, 2022)
Description of Registrants Securities (Filed With SEC on February 24, 2022)
Amended and Restated Agreement and Plan of Merger, dated as of February 20, 2020, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc (Filed With SEC on February 20, 2020)
License and Collaboration Agreement between Point Biopharma, Inc. and Lantheus Two, LLC, dated as of November 11, 2022 (Filed With SEC on November 14, 2022)
Form of Stock Option Award Agreement (Time Vesting) of Lantheus Holdings, Inc (Filed With SEC on April 29, 2022)
Form of Restricted Stock Unit Award Agreement (Relative Total Shareholder Return Performance-Based Vesting) of Lantheus Holdings, Inc (Filed With SEC on April 29, 2022)
Form of Restricted Stock Unit Award Agreement (Filed With SEC on April 29, 2022)
Manufacturing and Supply Agreement with Jubilant HollisterStier, effective as of February 23, 2022 (Filed With SEC on April 29, 2022)
Fifth Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan (Filed With SEC on April 29, 2021)
Consulting Agreement by and between Lantheus Medical Imaging, Inc. and Michael P. Duffy, dated as of March 31, 2021 (Filed With SEC on April 1, 2021)
Description of Registrants Securities (Filed With SEC on February 25, 2021)
Amendment No. 1 to Credit Agreement, dated as of June 19, 2020, among Lantheus Medical Imaging, Inc., as borrower, Lantheus Holdings, Inc. and Wells Fargo Bank, N.A., as... (Filed With SEC on July 31, 2020)
Contingent Value Rights Agreement, dated as of June 19, 2020, by and between Lantheus Holdings, Inc. and Computershare Trust Company, N.A., as rights agent (Filed With SEC on June 22, 2020)
Support Agreement, dated as of April 14, 2020, among Lantheus Holdings, Inc., Velan Capital, L.P., Altiva Management Inc., Velan Capital Partners LP, Velan Capital Holdings LLC,... (Filed With SEC on April 14, 2020)
Description of Registrants Securities (Filed With SEC on February 25, 2020)
Volume and Pricing Amendment, dated as of October 31, 2019, by and between Lantheus Medical Imaging, Inc. and NTP Radioisotopes (SOC) Ltd (Filed With SEC on February 25, 2020)
Form of Contingent Value Rights Agreement (Filed With SEC on February 20, 2020)
Agreement and Plan of Merger, dated as of October 1, 2019, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc (Filed With SEC on October 2, 2019)
Credit Agreement dated as of June 27, 2019 by and among Wells Fargo Bank, N.A., as administrative agent and collateral agent, each of the lenders from time to time party thereto,... (Filed With SEC on July 25, 2019)
Retirement Agreement, effective April 18, 2019, between Lantheus Medical Imaging, Inc. and Cesare Orlandi, M.D (Filed With SEC on July 25, 2019)
Third Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan (Filed With SEC on April 30, 2019)
Fourth Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan (Filed With SEC on April 26, 2019)
Employment Agreement dated as of November 22, 2013, by and between Lantheus Medical Imaging, Inc. and Michael Duffy (Filed With SEC on February 20, 2019)
Form of Severance Agreement (executives without existing employment agreements) (Filed With SEC on February 20, 2019)
Form of Severance Agreement (executives with existing employment agreements) (Filed With SEC on February 20, 2019)
Second Amended and Restated Employment Agreement, effective January 25, 2019, by and between Lantheus Medical Imaging, Inc. and Mary Anne Heino (Filed With SEC on February 20, 2019)